Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Construction In Progress: ¥859 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603456 Zhejiang Jiuzhou Pharmaceutical Co Ltd SHSE:603456
95 GF Score
Price ¥15.46
GF Value ¥16.96
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress?

Zhejiang Jiuzhou Pharmaceutical Co SHSE:603456 -1.72% 95 Construction In Progress is ¥859 Mil as of Jun. 2026. GuruFocus rates SHSE:603456 with a GF Score™ of 95/100 and a GF Value™ of ¥16.96 (Fairly Valued). The stock has 2 warning signs investors should review.

Zhejiang Jiuzhou Pharmaceutical Co's quarterly construction in progress increased from Dec. 2025 (¥757 Mil) to Mar. 2026 (¥843 Mil) and increased from Mar. 2026 (¥843 Mil) to Jun. 2026 (¥859 Mil).

Zhejiang Jiuzhou Pharmaceutical Co's annual construction in progress increased from Dec. 2023 (¥1,198 Mil) to Dec. 2024 (¥1,566 Mil) but then declined from Dec. 2024 (¥1,566 Mil) to Dec. 2025 (¥757 Mil).

Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 471.51 839.25 1,198.29 1,566.32 757.46

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,668.58 1,280.49 757.46 842.80 858.81
SHSE:603456
95GF Score
Zhejiang Jiuzhou Pharmaceutical Co Ltd SHSE:603456
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Jiuzhou Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥859 Mil mean?
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) has a Construction In Progress of ¥859 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors.
Is Zhejiang Jiuzhou Pharmaceutical Co's Construction In Progress too high?
Zhejiang Jiuzhou Pharmaceutical Co's current Construction In Progress is ¥859 Mil. Overall, Zhejiang Jiuzhou Pharmaceutical Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Jiuzhou Pharmaceutical Co's Construction In Progress compare to ZTS?
Zhejiang Jiuzhou Pharmaceutical Co's Construction In Progress of ¥859 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. Zhejiang Jiuzhou Pharmaceutical Co's current Construction In Progress is ¥859 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Jiuzhou Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.96, compared to a current price of ¥15.46 — trading 8.8% below its estimated fair value. The current Construction In Progress is ¥859 Mil. Zhejiang Jiuzhou Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456), the current Construction In Progress is ¥859 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥15.46 is trading 8.8% below its estimated GF Value™ of ¥16.96. GuruFocus considers Zhejiang Jiuzhou Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603456:

  • Construction In Progress: ¥859 Mil
  • GF Value™: ¥16.96 vs. price of ¥15.46 (8.8% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603456 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Jiuzhou Pharmaceutical Co Business Description

Address No. 99 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
95GF Score

Get the complete analysis for SHSE:603456

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.46
Price
¥16.96
GF Value